Dogs have been widely used as a preclinical model for human disease. With the successful generation of canine induced pluripotent stem cells (ciPSCs), the biomedical community has a unique opportunity to study therapeutic interventions using autologous stem cells that can benefit dogs and humans. Unlike mice and human pluripotent cells, which are leukemia inhibitory factor (LIF)– and basic fibroblast growth factor (bFGF)–dependent, respectively, dog iPSCs require both growth factors simultaneously. In an effort to elucidate the role of each factor in the control of ciPSC self-renewal, we performed a series of experiments aiming at understanding the signaling pathways activated by them. We found that bFGF regulates pluripotency by indirectly activating the SMAD2/3 pathway in the presence of feeder cells, exclusively targeting NANOG expression, and inhibiting spontaneous differentiation toward ectoderm and mesoderm. LIF activates the JAK-STAT3 pathway but does not function in the typical manner described in mouse naïve embryonic stem cells. These results show that a unique mechanism for maintenance of pluripotency is present in ciPSC. These findings should be taken into account when establishing stem cell differentiation protocols and may provide more insight into pluripotency regulation in species other than mice and humans.
Get full access to this article
View all access options for this article.
References
1.
VaagsAK, Rosic-KablarS, GartleyCJ, ZhengYZ, ChesneyA, VillagomezDA, KruthSA and HoughMR. (2009). Derivation and characterization of canine embryonic stem cell lines with in vitro and in vivo differentiation potential. Stem Cells, 27:329–340.
2.
HayesB, FagerlieSR, RamakrishnanA, BaranS, HarkeyM, GrafL, BarM, BendoraiteA, TewariM and Torok-StorbB. (2008). Derivation, characterization, and in vitro differentiation of canine embryonic stem cells. Stem Cells, 26:465–473.
3.
SchneiderMR, WolfE, BraunJ, KolbHJ and AdlerH. (2010). Canine embryonic stem cells: state of the art. Theriogenology, 74:492–497.
4.
HatoyaS, ToriiR, KondoY, OkunoT, KobayashiK, WijewardanaV, KawateN, TamadaH, SawadaT, et al. (2006). Isolation and characterization of embryonic stem-like cells from canine blastocysts. Mol Reprod Dev, 73:298–305.
5.
WilcoxJT, SempleE, GartleyC, BrissonBA, PerraultSD, VillagomezDA, TayadeC, BeckerS, LanzaR and BettsDH. (2009). Characterization of canine embryonic stem cell lines derived from different niche microenvironments. Stem Cells Dev, 18:1167–1178.
6.
LuoJ, SuhrST, ChangEA, WangK, RossPJ, NelsonLL, VentaPJ, KnottJG and CibelliJB. (2011). Generation of leukemia inhibitory factor and basic fibroblast growth factor-dependent induced pluripotent stem cells from canine adult somatic cells. Stem Cells Dev, 20:1669–1678.
7.
ShimadaH, NakadaA, HashimotoY, ShigenoK, ShionoyaY and NakamuraT. (2010). Generation of canine induced pluripotent stem cells by retroviral transduction and chemical inhibitors. Mol Reprod Dev, 77:2.
8.
LeeAS, XuD, PlewsJR, NguyenPK, NagD, LyonsJK, HanL, HuS, LanF, et al. (2011). Preclinical derivation and imaging of autologously transplanted canine induced pluripotent stem cells. J Biol Chem, 286:32697–32704.
9.
KohS and PiedrahitaJA. (2015). Generation of Induced Pluripotent Stem Cells (iPSCs) from adult canine fibroblasts. Methods Mol Biol, 1330:69–78.
10.
MatsudaT, NakamuraT, NakaoK, AraiT, KatsukiM, HeikeT and YokotaT. (1999). STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J, 18:4261–4269.
11.
GreberB, WuG, BernemannC, JooJY, HanDW, KoK, TapiaN, SabourD, SterneckertJ, TesarP and ScholerHR. (2010). Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cells. Cell Stem Cell, 6:215–226.
12.
NiwaH, BurdonT, ChambersI and SmithA. (1998). Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev, 12:2048–2060.
13.
OkitaK and YamanakaS. (2006). Intracellular signaling pathways regulating pluripotency of embryonic stem cells. Curr Stem Cell Res Ther, 1:103–111.
14.
LannerF and RossantJ. (2010). The role of FGF/Erk signaling in pluripotent cells. Development, 137:3351–3360.
15.
WeiCL, MiuraT, RobsonP, LimSK, XuXQ, LeeMY, GuptaS, StantonL, LuoY, et al. (2005). Transcriptome profiling of human and murine ESCs identifies divergent paths required to maintain the stem cell state. Stem Cells, 23:166–185.
16.
ChambersSM, FasanoCA, PapapetrouEP, TomishimaM, SadelainM and StuderL. (2009). Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol, 27:275–280.
17.
YuasaS, ItabashiY, KoshimizuU, TanakaT, SugimuraK, KinoshitaM, HattoriF, FukamiS, ShimazakiT, et al. (2005). Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat Biotechnol, 23:607–611.
18.
SuhrST, ChangEA, RodriguezRM, WangK, RossPJ, BeyhanZ, MurthyS and CibelliJB. (2009). Telomere dynamics in human cells reprogrammed to pluripotency. PLoS One, 4:e8124.
19.
RossPJ, SuhrS, RodriguezRM, ChangEA, WangK, SiripattarapravatK, KoT and CibelliJB. (2010). Human induced pluripotent stem cells produced under xeno-free conditions. Stem Cells Dev, 19:1221–1229.
20.
JefferyND, SmithPM, LakatosA, IbanezC, ItoD and FranklinRJ. (2006). Clinical canine spinal cord injury provides an opportunity to examine the issues in translating laboratory techniques into practical therapy. Spinal Cord, 44:584–593.
21.
KohS, ThomasR, TsaiS, BischoffS, LimJH, BreenM, OlbyNJ and PiedrahitaJA. (2013). Growth requirements and chromosomal instability of induced pluripotent stem cells generated from adult canine fibroblasts. Stem Cells Dev, 22:951–963.
GriffithsDS, LiJ, DawsonMA, TrotterMW, ChengYH, SmithAM, MansfieldW, LiuP, KouzaridesT, et al. (2011). LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease. Nat Cell Biol, 13:13–21.
24.
DarrH, MaysharY and BenvenistyN. (2006). Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development, 133:1193–1201.
25.
DolezalovaD, MrazM, BartaT, PlevovaK, VinarskyV, HolubcovaZ, JarosJ, DvorakP, PospisilovaS and HamplA. (2012). MicroRNAs regulate p21(Waf1/Cip1) protein expression and the DNA damage response in human embryonic stem cells. Stem Cells, 30:1362–1372.
26.
GartelAL and TynerAL. (2002). The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther, 1:639–649.
27.
WadaT, PippinJW, TeradaY and ShanklandSJ. (2005). The cyclin-dependent kinase inhibitor p21 is required for TGF-beta1-induced podocyte apoptosis. Kidney Int, 68:1618–1629.
28.
TrouillasM, SaucourtC, DuvalD, GauthereauX, ThibaultC, DembeleD, FeraudO, MenagerJ, RalluM, PradierL and BoeufH. (2008). Bcl2, a transcriptional target of p38alpha, is critical for neuronal commitment of mouse embryonic stem cells. Cell Death Differ, 15:1450–1459.
29.
DuvalD, MalaiseM, ReinhardtB, KedingerC and BoeufH. (2004). A p38 inhibitor allows to dissociate differentiation and apoptotic processes triggered upon LIF withdrawal in mouse embryonic stem cells. Cell Death Differ, 11:331–341.
30.
RoosWP, ChristmannM, FraserST and KainaB. (2007). Mouse embryonic stem cells are hypersensitive to apoptosis triggered by the DNA damage O(6)-methylguanine due to high E2F1 regulated mismatch repair. Cell Death Differ, 14:1422–1432.
31.
SatoN, MeijerL, SkaltsounisL, GreengardP and BrivanlouAH. (2004). Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med, 10:55–63.
32.
HsiehYC, IntawichaP, LeeKH, ChiuYT, LoNW and JuJC. (2011). LIF and FGF cooperatively support stemness of rabbit embryonic stem cells derived from parthenogenetically activated embryos. Cell Reprogram, 13:241–255.
33.
ChengD, GuoY, LiZ, LiuY, GaoX, GaoY, ChengX, HuJ and WangH. (2012). Porcine induced pluripotent stem cells require LIF and maintain their developmental potential in early stage of embryos. PLoS One, 7:e51778.
34.
CaoH, YangP, PuY, SunX, YinH, ZhangY, LiY, LiuY, FangF, et al. (2012). Characterization of bovine induced pluripotent stem cells by lentiviral transduction of reprogramming factor fusion proteins. Int J Biol Sci, 8:498–511.
35.
EzashiT, TeluguBP, AlexenkoAP, SachdevS, SinhaS and RobertsRM. (2009). Derivation of induced pluripotent stem cells from pig somatic cells. Proc Natl Acad Sci U S A, 106:10993–10998.
36.
GafniO, WeinbergerL, MansourAA, ManorYS, ChomskyE, Ben-YosefD, KalmaY, ViukovS, MazaI, et al. (2013). Derivation of novel human ground state naive pluripotent stem cells. Nature, 504:282–286.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
